Search
for
Sort by
Research 31–60 of 1000+
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- Synthesis and Pharmacological Evaluation of New Progesterone Esters as 5.ALPHA.-Reductase Inhibitors
- Association Between 5-Alpha Reductase Inhibitor Use and The Risk of Depression: A Meta-Analysis.
- Bladder cancer survival in men using 5-alpha-reductase inhibitors
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.
- Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5‐Alpha Reductase Inhibitor Therapy
- Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function
- The relevance of using 5α-reductase inhibitors in the conservative management of benign prostatic hyperplasia: A review
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- Computer Based Screening of Selected Phytoconstituents from Cyperus Rotundus Linn. Against 5 α Reductase Enzyme
- Evaluating 5 alpha reductase inhibitors for the treatment of male androgenic alopecia
- 5‐alpha‐reductase inhibitor treatment for frontal fibrosing alopecia: an evidence‐based treatment update
- Fast Motions in 5 Alpha Reductase and Its Impact on Enzyme Kinetics
- Finasteride Treatment Inhibits Adult Hippocampal Neurogenesis in Male Mice
- HPLC characterization, molecular docking, QSAR and molecular dynamics simulation of Alstonia boonei phytochemical analogs as potent 5-alpha reductase inhibitors
- Adverse effects of the 5-alpha-reductase inhibitor finasteride on Daphnia magna: Endocrine system and lipid metabolism disruption
- Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease
- 5α-Reductase type 1 inhibition of Oryza sativa bran extract prepared by supercritical carbon dioxide fluid
- Role of 5 alpha-reductase inhibitors in the management of prostate cancer
- The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
- Use of 5-Alpha Reductase Inhibitors in Dermatology: A Narrative Review
- Finasteride: the first 5 alpha-reductase inhibitor.
- Dutasteride nanoemulsion preparation to inhibit 5-alpha-hair follicle reductase enzymes in the hair follicle; an ex vivo study.
- 5α-Reductase inhibitors in androgenetic alopecia
- Steroid Hormones
- The corpus cavernosum after treatment with dutasteride or finasteride: A histomorphometric study in a benign prostatic hyperplasia rodent model
- Homology Modeling of 5-alpha-Reductase 2 Using Available Experimental Data
- New Drugs: Dutasteride
- Pharmacophore Modeling and Three Dimensional Database Searching for Drug Design Using Catalyst: Recent Advances